IBDEI132 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19304,2)
 ;;=^329980
 ;;^UTILITY(U,$J,358.3,19305,0)
 ;;=V58.66^^106^1135^25
 ;;^UTILITY(U,$J,358.3,19305,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19305,1,2,0)
 ;;=2^V58.66
 ;;^UTILITY(U,$J,358.3,19305,1,5,0)
 ;;=5^L/T (Current) Aspirin Use
 ;;^UTILITY(U,$J,358.3,19305,2)
 ;;=^331584
 ;;^UTILITY(U,$J,358.3,19306,0)
 ;;=V58.67^^106^1135^27
 ;;^UTILITY(U,$J,358.3,19306,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19306,1,2,0)
 ;;=2^V58.67
 ;;^UTILITY(U,$J,358.3,19306,1,5,0)
 ;;=5^L/T (Current) Insulin Use
 ;;^UTILITY(U,$J,358.3,19306,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,19307,0)
 ;;=V58.68^^106^1135^26
 ;;^UTILITY(U,$J,358.3,19307,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19307,1,2,0)
 ;;=2^V58.68
 ;;^UTILITY(U,$J,358.3,19307,1,5,0)
 ;;=5^L/T (Current) Bisphos Use
 ;;^UTILITY(U,$J,358.3,19307,2)
 ;;=^340624
 ;;^UTILITY(U,$J,358.3,19308,0)
 ;;=V58.69^^106^1135^29
 ;;^UTILITY(U,$J,358.3,19308,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19308,1,2,0)
 ;;=2^V58.69
 ;;^UTILITY(U,$J,358.3,19308,1,5,0)
 ;;=5^L/T (Current) Other Meds Use
 ;;^UTILITY(U,$J,358.3,19308,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,19309,0)
 ;;=V58.83^^106^1135^50
 ;;^UTILITY(U,$J,358.3,19309,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19309,1,2,0)
 ;;=2^V58.83
 ;;^UTILITY(U,$J,358.3,19309,1,5,0)
 ;;=5^Therapeutic Drug Monitoring
 ;;^UTILITY(U,$J,358.3,19309,2)
 ;;=^322076
 ;;^UTILITY(U,$J,358.3,19310,0)
 ;;=V62.5^^106^1135^32
 ;;^UTILITY(U,$J,358.3,19310,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19310,1,2,0)
 ;;=2^V62.5
 ;;^UTILITY(U,$J,358.3,19310,1,5,0)
 ;;=5^Legal Circumstances
 ;;^UTILITY(U,$J,358.3,19310,2)
 ;;=^175799
 ;;^UTILITY(U,$J,358.3,19311,0)
 ;;=V79.1^^106^1136^1
 ;;^UTILITY(U,$J,358.3,19311,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19311,1,2,0)
 ;;=2^V79.1
 ;;^UTILITY(U,$J,358.3,19311,1,5,0)
 ;;=5^Alcohol Screen
 ;;^UTILITY(U,$J,358.3,19311,2)
 ;;=^295678
 ;;^UTILITY(U,$J,358.3,19312,0)
 ;;=V61.21^^106^1136^8
 ;;^UTILITY(U,$J,358.3,19312,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19312,1,2,0)
 ;;=2^V61.21
 ;;^UTILITY(U,$J,358.3,19312,1,5,0)
 ;;=5^Victim Child Abuse Counseling
 ;;^UTILITY(U,$J,358.3,19312,2)
 ;;=^304301
 ;;^UTILITY(U,$J,358.3,19313,0)
 ;;=V65.40^^106^1136^2
 ;;^UTILITY(U,$J,358.3,19313,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19313,1,2,0)
 ;;=2^V65.40
 ;;^UTILITY(U,$J,358.3,19313,1,5,0)
 ;;=5^Counseling NOS
 ;;^UTILITY(U,$J,358.3,19313,2)
 ;;=^87449
 ;;^UTILITY(U,$J,358.3,19314,0)
 ;;=V65.42^^106^1136^7
 ;;^UTILITY(U,$J,358.3,19314,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19314,1,2,0)
 ;;=2^V65.42
 ;;^UTILITY(U,$J,358.3,19314,1,5,0)
 ;;=5^Substance Use/Abuse Counseling
 ;;^UTILITY(U,$J,358.3,19314,2)
 ;;=^303467
 ;;^UTILITY(U,$J,358.3,19315,0)
 ;;=V65.44^^106^1136^3
 ;;^UTILITY(U,$J,358.3,19315,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19315,1,2,0)
 ;;=2^V65.44
 ;;^UTILITY(U,$J,358.3,19315,1,5,0)
 ;;=5^HIV Counseling
 ;;^UTILITY(U,$J,358.3,19315,2)
 ;;=^303469
 ;;^UTILITY(U,$J,358.3,19316,0)
 ;;=V65.49^^106^1136^5
 ;;^UTILITY(U,$J,358.3,19316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19316,1,2,0)
 ;;=2^V65.49
 ;;^UTILITY(U,$J,358.3,19316,1,5,0)
 ;;=5^Oth Specified Counseling
 ;;^UTILITY(U,$J,358.3,19316,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,19317,0)
 ;;=V68.1^^106^1136^4
 ;;^UTILITY(U,$J,358.3,19317,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19317,1,2,0)
 ;;=2^V68.1
 ;;^UTILITY(U,$J,358.3,19317,1,5,0)
 ;;=5^Issue Repeat Prescription
 ;;^UTILITY(U,$J,358.3,19317,2)
 ;;=^295585
 ;;^UTILITY(U,$J,358.3,19318,0)
 ;;=V70.2^^106^1136^6
 ;;^UTILITY(U,$J,358.3,19318,1,0)
 ;;=^358.31IA^5^2
